Janux Therapeutics Inc (JANX)

R&D Expenses

$30.99M

Quarterly · Period ending: · USD

JANX logo

JANX R&D Expenses

Latest reported$30.99M
JANX Quarterly R&D Expenses ($549.00K → $30.99M)
High-resolution chart · PNG

JANX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
30,994,000
26,813,000
31,548,000
34,629,000
34,664,000
25,055,000
20,806,000
18,614,000
14,898,000
14,070,000
12,241,000
11,892,000
14,924,000
15,865,000
15,434,000
13,737,000
14,086,000
10,184,000
11,169,000
8,406,000
4,737,000
1,925,000
985,000
834,000
673,000
549,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.